Giovanna Digiesi

Author PubWeight™ 8.28^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia.	Leuk Res	2007	1.48
2	Increased serum levels of matrix metalloproteinase-9 predict clinical outcome of patients with early B-cell chronic lymphocytic leukaemia.	Eur J Haematol	2003	0.95
3	Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL).	Leuk Res	2011	0.91
4	Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia.	Leuk Res	2008	0.86
5	Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia.	Eur J Haematol	2010	0.86
6	Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemia.	Eur J Haematol	2009	0.83
7	Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia.	Int J Hematol	2008	0.82
8	Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.	Eur J Haematol	2004	0.81
9	Does adiponectin act as an antiangiogenic factor in B-cell chronic lymphocytic leukemia?	Adv Hematol	2009	0.76
10	Serum thrombopoietin compared with ZAP-70 and immunoglobulin heavy-chain gene mutation status as a predictor of time to first treatment in early chronic lymphocytic leukemia.	Leuk Lymphoma	2008	0.75